Literature DB >> 34733979

Propofol protects hippocampal neurons in sleep-deprived rats by inhibiting mitophagy and autophagy.

Weixin Dai1, Yong Xiao1, Youbing Tu1, Fei Xiao1, Yizhi Lu1, Yinying Qin1, Yubo Xie1.   

Abstract

BACKGROUND: Sleep deprivation (SD) causes a disturbance in the cognitive function of rats. While propofol has a powerful sedative and hypnotic effect and is an antioxidant, its effect on the cognitive function of rats following SD remains unknown. The purpose of this study was to explore the protective effects of propofol on excessive autophagy and mitophagy in the hippocampus of rats after SD.
METHODS: Adult male rats were intraperitoneally injected with 30 mg/kg of propofol after 96 hours of SD. Then we evaluated the effect of propofol on the cognitive function of sleep deprived rats by the Morris water maze. Transmission electron microscopy, Western blotting, PCR, immunohistochemistry, autophagy enhancer and autophagy inhibitor were used to study the effect of propofol on hippocampal neurons of rat with excessive autophagy and mitophagy.
RESULTS: The behavioral experimental results of the Morris water maze showed that propofol improved the learning and memory ability of sleep-deprived rats. The expression of Beclin1, PINK1, parkin, p62, and LC3 protein increased significantly after sleep deprivation. While the intervention of propofol could significantly reduce the expression of these proteins, rapamycin treatment eliminated this effect.
CONCLUSIONS: Our findings showed that propofol could reduce the impairment of learning and memory in sleep-deprived rats by inhibiting excessive autophagy and mitophagy in hippocampal neurons. This strategy may provide an application basis for the clinical use of propofol in patients with chronic insomnia. 2021 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Sleep deprivation (SD); autophagy; cognitive function; mitophagy; propofol

Year:  2021        PMID: 34733979      PMCID: PMC8506745          DOI: 10.21037/atm-21-3872

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


Introduction

Sleep deprivation (SD) can lead to disturbances in the energy metabolism of nerve cells (1,2), and intermittent sleep causes changes in energy metabolism in the brain. Chronic SD is known to cause mild neuroinflammation in rats, which in turn shows anxiety, decreased learning and memory (3). Even short-term SD has been found to impair the plasticity and memory of hippocampal neurons (4). SD can cause mitochondrial damage and oxidative stress in the hippocampus of rats (5), has been shown to reduce the membrane excitability of CA1 pyramidal neurons, and can induce Bax to migrate from the cytoplasm to the mitochondria, resulting in the release of cytochrome C into the cytoplasm (6). Autophagy is a highly conservative biological process in which cells capture and degrade their cytoplasmic components. Under physiological conditions, the main purpose of autophagy activation is to adjust intracytoplasmic components and to regulate energy metabolism and maintain cellular homeostasis to promote cell survival (7). Recently, studies have reported that sleep deprivation may cause autophagy disorders in hippocampal neurons (8). An imbalance of autophagy may also affect long-term spatial memory formation in male rats (9). However, autophagy is regulated by a range of different factors (10), and its insufficient and excessive levels are harmful to neurons in the hippocampus (11). Mitophagy is a form of selective macro-autophagy resulting in damaged mitochondria being surrounded by autophagosomes. While mitochondrial damage induces apoptosis, milder mitochondrial damage can also induce autophagy (12). During stress, reactive oxygen species (ROS) are released from both the endoplasmic reticulum and mitochondria and can cause damage to the mitochondrial membrane (13). When cellular metabolism is abnormal or under environmental stress, mitochondria will fissure into populations of both damaged and healthy types. While healthy mitochondria fuse with other healthy mitochondria in a process that is mediated by mitochondrial fusion proteins, damaged mitochondria trigger the process of mitophagy and are removed from the cell (14). In brief, the mitochondrial quality control system maintains the dynamic balance of mitochondria via fusion and fission, which depends on the metabolic needs of cells under various physiological and pathological conditions. PTEN-induced putative kinase 1 (PINK1) is a serine/threonine-protein kinase induced by PTEN capable of removing damaged mitochondria by inducing mitophagy to maintain mitochondrial stability. Parkin is a cytoplasmic E3 ligase, and its absence can cause abnormal mitochondrial morphology. While these two proteins are the key to mitophagy, the effect of SD on mitophagy has not yet been reported. Propofol is widely used as an intravenous anesthetic, and with a molecular structure similar to phenolic antioxidants, can also exert an antioxidant effect (15). Natural sleep, in common with states of anesthesia, is actively generated by the brain, suggesting a potential overlap in neuronal circuitry (16). By analyzing the high-density EEG performance of both propofol-induced anesthesia and natural sleep, researchers have forwarded the hypothesis that propofol-induced general anesthesia resembles a sleep-like state (17). Propofol has been used to treat patients with refractory chronic primary insomnia, and found to be safe and effective, and improved the sleep quality of patients for a long period after treatment (18). The sleep produced by propofol not only causes effects associated with SD (19) but can also rescue the sleep debt of rats following SD (20). In a previous study, Cui and colleagues subjected PC12 nerve cells to oxygen deprivation and found that the level of autophagy was significantly increased. However, propofol intervention was shown to induce a reduction in the expression of autophagy-related proteins concomitant with an increase in nerve cell survival, indicating it had a protective effect on nerves (21). However, the neuroprotective effect of propofol in SD remains unclear. In this study we aimed to understand the specific effect of propofol-induced sleep on the hippocampus of rats after SD and identify the potential mechanisms underlying this effect. We present the following article in accordance with the ARRIVE reporting checklist (available at https://dx.doi.org/10.21037/atm-21-3872).

Methods

Animals and treatment

Male Sprague-Dawley rats were obtained from the Animal Experimental Center of Guangxi Medical University, China (weight: 260–320 g; age: 9–12 weeks-of-age) and were maintained in its Animal Experiment Center. All animal procedures were approved by the Animal Ethics Committee of Guangxi Medical University (No. 2017050029, Nanning, Guangxi, China), in compliance with the animal experiment specifications of Guangxi Medical University and the experimental animal welfare ethical review guidelines (GB/T 35892-2018) for the care and use of animals. A protocol was prepared before the study without registration. To avoid interference between experimental and control groups, rats in the normal control group were kept in a separate room, while conditions in the two experimental animal rooms were standardized concerning sound, light, temperature, and humidity. Lights in the rooms (provided by a 40W incandescent lamp) were automatically turned on from 6:30 a.m. to 6:30 p.m., then turned off automatically from 6:30 p.m. to 6:30 a.m., and the ambient temperature was set to 23±2 °C and humidity 55%±15%. Each rat was labeled and numbered with an odor-free color on its back. To evaluate the effect of different doses of propofol on the expression of Beclin1 protein in SD rats, we randomly them into a control group, SD group, propofol (5 mg/kg) group, propofol (10 mg/kg) group, propofol (15 mg/kg) group, propofol (30 mg/kg) group, and a propofol (60 mg/kg) group. Three rats were allocated to each of the eight groups. Rats in the control group (without SD) were fed by conventional methods, while those in all other groups used the modified multi-platform SD method for SD for a total period of 4 days (96 hours). Following the completion of SD, rats were dosed and subsequently tested. Rats in the control and SD group were given 1 mL of normal saline via intraperitoneal injection, while those in the propofol groups were given intraperitoneal injections of propofol at different doses (5, 10, 15, 30, and 60 mg/kg) after SD. To confirm the effect of the autophagy pathway on propofol in reducing hippocampal damage, we randomly divided 112 rats into a control group (C group), SD group, SD + intralipid group (SD-F group), SD + propofol (30 mg/kg) group (P group), SD + rapamycin (0.5 mg/kg) group (R group), SD + rapamycin (0.5 mg/kg) + propofol (30 mg/kg) group (PR group), SD + 3-methyladenine (3-MA) (0.5mg/kg) group (3-MA group), and SD + 3-MA (0.5 mg/kg) + propofol (30 mg/kg) group (P + 3-MA group). Fourteen rats were allocated to each of the eight groups. Following SD, rats were given intraperitoneal injections of 1 mL of normal saline, 1 mL of 10% intralipid, 30 mg/kg of propofol, 0.5 mg/kg of rapamycin, and 0.5 mg/kg of 3-MA. Rats in the SD + rapamycin (0.5 mg/kg) + propofol (30 mg/kg) group and SD + 3-MA (0.5 mg/kg) + propofol (30 mg/kg) group were given intraperitoneal injections of 30 mg/kg of propofol half an hour after the injection of rapamycin or 3-MA. To investigate the role of the PINK1/Parkin mitophagy pathway in the restorative effect of propofol on hippocampal mitochondrial damage after SD, 45 rats were randomly divided a control group, SD group, propofol (5 mg/kg) group, propofol (30 mg/kg) group, and propofol (60 mg/kg) group, with nine rats in each of the five groups. After SD, rats were given intraperitoneal injections of 1 mL of normal saline, 1 mL of 10% intralipid, 30 mg/kg of propofol, or 60 mg/kg of propofol.

Establishment of a rat model of rapid eye movement (REM) sleep deprivation

We used the modified multi-platform SD method to establish a rat model of rapid eye movement (REM) SD (22,23). The core mechanism underlying this technique is that body muscle tension will reduce after the animals enter the REM sleep period. The water level of the device was set in a suitable position so that the rats would still need to maintain a certain amount of neck muscle tension to avoid their nose touching the water when awake. If they entered the REM sleep period due to a reduction in muscle tension, they developed head ptosis, causing their nose to touch the water, waking the animal up, resulting in a REM SD effect. The device was made of plexiglass (5 mm thick), measured 95 cm × 75 cm × 60 cm, and contained 12 small platforms with a diameter of 5 cm, height of 15 cm, and platform interval of 15 cm. Rats could move freely between each platform and the platform surface. The water level was 2 cm higher than the platform, forcing the rats to stand on the platform while maintaining a head-up position to avoid the nostrils falling into the water. The temperature of the water in the device was maintained at 23±1 °C with a thermostat. Sterile drinking water and food were provided at the top of the device and were available ad libitum. The water in the platform of the device was replaced at regular times (12 noon to 1 PM) and the device was cleaned carefully, during which time all rats were moved to a clean and dry box. While rats could move freely, eat, and drink, they were not permitted to sleep. If rats were found to be still and closed their eyes for more than 1 minute, the box was shaken until they were awoken. After cleaning, rats were moved back to the platform. The control group was placed in the same device, but without water. Rats in the control group were also allowed to sleep. Prior to the SD experiment, all rats were acclimatized to the device environment for 15 minutes, once a day for 3 days. The timeline of sleep deprivation, drug intervention, and behavioral experiments is shown in .
Figure 1

Experiment timeline.

Experiment timeline.

Morris water maze

The Morris water maze device (Institute of Materials, Chinese Academy of Medical Sciences) consists of a water tank, an automatic track imaging recording device (with a camera fixed on the top of the water tank), and a computer with a track analysis and statistical analysis system (24,25). A round barrel stainless steel tank with a diameter of 1.5 m, a height of 45 cm, and a water depth of 20 cm was also used. The tank was divided into four quadrants, with each quadrant of the inner wall marked with four different shapes using black tape, and the water temperature was maintained at 23–25 °C. A platform was fixed in the southwest quadrant and submerged 2 cm below the surface, and the position of the platform remained unchanged for five consecutive days. A small amount of black ink was injected into the water to prevent rats from seeing the platform directly. During the experiment, a yellow shading cloth was used to surround the water tank to prevent the effect of automatic track recording from being disturbed by light and shadows arising from waves in the water.

Hidden platform exploration tests

During training, the rats were placed, in turn, into the water from four different quadrants (southwest → northwest → northeast → southeast) and were allowed to locate the submerged platform in the southwest quadrant of the tank. If a rat failed to find the submerged platform within 120 seconds, an assistant guided it towards the platform. After standing on the platform for 10 seconds, the rats were moved to a safe, dry, and warm place, to allow rest for two minutes before the next session. Escape latency was defined as the time for rats to find the submerged platform four times a day and was averaged over the four replicates.

Space exploration tests

This experiment was conducted on the 6th day after SD. After the submerged platform in the southwest quadrant was removed, the rats were placed into the water from the northwest quadrant. The swimming track of the rats was then recorded for over 60 seconds. Then recorded the retention time in the southwest quadrant and the number of times in which the rats crossed the position of the removed platform. This experiment was only performed once for each rat.

Transmission electron microscopy

All rats were sacrificed immediately after the intervention treatment, with the hippocampus removed then soaked in 3% glutaraldehyde at 4 °C for 2 hours. Hippocampal tissue was then cut into inducing 2 mm × 2 mm ×2 mm pieces then dehydrated step by step using ethanol and acetone. Finally, the specimens were embedded in epoxy resin, stained with uranyl acetate and lead citrate, and observed using an H‐7650 electron microscope (Hitachi, Tokyo, Japan).

Immunohistochemistry

Brain tissue was embedded in wax blocks, cut into 4-µm sections (Leica, China), and stored in a refrigerator at 4 °C. When preparing the experiment, the sections were warmed to room temperature and dewaxed to water, then incubated in 3% hydrogen peroxide for 20 minutes and transferred to a tris buffered saline (TBS)-based blocking solution containing 5% bovine serum albumin and 0.1% Tween-20 for 12 minutes. Sections were then incubated with a rabbit LC3A/B monoclonal antibody (1:500, Cell Signaling Technology, USA), a rabbit Pink1 polyclonal antibody (1:100, Affinity Biosciences. the USA), and a rabbit PARK2/Parkin polyclonal antibody (1:200, Proteintech Group, USA) at 4 °C overnight. The following morning, sections were washed with PBS then incubated in IRDye 680RD Goat anti-Rabbit IgG (1:500, LI-COR Biosciences, USA) at room temperature for 12 minutes. Sections were then treated with Streptavidin/HRP and incubated for 10 minutes. Finally, the sections were washed with PBS, developed with 3,3-diaminobenzidine (DAB), stained with Hematoxylin, and microscopically examined. Fluorescent images were taken with an Olympus VS120 Virtual Slide Scanner.

Western blotting

Shredded hippocampus tissue was homogenized in a lysis buffer containing RIPA lysis buffer (Roche, USA), phenylmethylsulfonyl fluoride (PMSF), and phosphatase inhibitors (Solarbio, Beijing, China) in a one-to-one ratio. After 30 minutes of lysis, the samples were centrifuged at 12,000 rpm for 5min at 4 °C, and the supernatants removed. A protein standard curve was then prepared using a bovine serum albumin standard solution (1 mg/mL), and the protein concentration of the supernatants was determined by a microplate reader using a bovine serum protein concentration determination kit (Solarbio, Beijing, China). Proteins were then separated using 12% SDS-PAGE, transferred to a PVDF membrane, then incubated overnight at 4 °C with primary antibodies, including rabbit LC3A/B monoclonal antibody (1:1,000, Cell Signaling Technology, USA), rabbit Pink1 polyclonal antibody (1:1,000, Affinity Biosciences, USA), rabbit PARK2/Parkin polyclonal antibody (1:1,000, Proteintech Group, USA), rabbit Beclin1 monoclonal antibody (1:1,000, Cell Signaling Technology, USA), and rabbit p62 polyclonal antibody (1:1,000, Cell Signaling Technology, USA). IRDye 680RD Goat anti-Rabbit IgG (1:15,000, LI-COR Biosciences, USA) was then added and incubated at room temperature for 2 hours. The PVDF membranes were then scanned with the Odyssey two-color fluorescence imaging system and the bands were analyzed using Odyssey (LI-COR Biosciences, USA) and Image J software (NIH, USA). The ratio of the gray value of the target protein band to the gray value of the internal reference (GAPDH) band was expressed as the relative expression level of the protein.

RT-PCR

Total RNA was isolated using a Total RNA Extraction Kit 9108-9109 (Takarabiomed, Beijing, China), and a reverse transcription Kit (RR047A, Takarabiomed, Beijing, China) was used for cDNA synthesis. Quantitative RT-PCR for the genes of interest was then performed with an Amplification kit (RR820A, Takarabiomed, Beijing, China) and a PCR machine (Thermo Scientific, USA) following the manufacturer’s protocols. Primers were provided by Sango Biotech (Shanghai, China), and the primer pairs for each gene of interest were as follows: PINK1: forward 5'-CATGGCTTTGGATGGAGAGT-3', reverse 5'-TGGGAGTTTGCTCTTCAAGG-3'; Parkin: forward 5'-CTGGCAGTCATTCTGGACAC-3', reverse 5'-CTCTCCACTCATCCGGTTTG-3'; LC3: forward 5'-CTTCGCCGACCGCTGTAA-3', reverse 5'-ATCCGTCTTCATCCTTCTCCTG-3'; GAPDH: forward 5'-ACAGCAACAGGGTGGTGGAC-3', reverse 5'-TTTGAGGGTGCAGCGAACTT-3'.

Statistical analyses

All statistical analyses were performed with SPSS version 22.0 (IBM, USA) and GraphPad Prism version 8.3 (GraphPad Software, USA) software. All measurement data are expressed as mean ± standard deviation (SD) and were tested for normal distributions and homogeneity of variance. The results of the Morris water maze behavior experiment were tested by multiple factor analysis of variance (ANOVA) for repeated measurements, and one-way ANOVA was used for intra-group comparisons. The least significant difference (LSD) test was used for comparisons between groups and P<0.05 was considered to represent statistical significance.

Results

Effect of different doses of propofol on Beclin1 protein expression in SD rats

Following SD, rats in each group received an intraperitoneal injection of propofol at a concentration of 5, 10, 15, 30, 45, or 60 mg/kg. The expression of Beclin1 protein was then detected after the rats were awoken. As shown in , the expression of Beclin1 protein in rats was significantly increased after SD. However, when propofol administration reached a concentration of 30 mg/kg in SD rats, a significant reduction in the expression levels of Beclin1 protein was observed, although, when the dose of propofol was increased, the trend for reduction did not increase linearly. This showed 30 mg/kg was the lowest effective dose of propofol that can reduce autophagic damage in SD rats and we used this dose as an interventional factor to influence autophagy in the next experiment.
Figure 2

Effects of various doses of propofol on the levels of Beclin1 protein. (A) Western blotting bands of Beclin1 in the hippocampus of rats; (B) the effects of various doses of propofol on the levels of Beclin1 protein. #P<0.05, significantly different from the SD group.

Effects of various doses of propofol on the levels of Beclin1 protein. (A) Western blotting bands of Beclin1 in the hippocampus of rats; (B) the effects of various doses of propofol on the levels of Beclin1 protein. #P<0.05, significantly different from the SD group.

Role of the autophagy pathway in the propofol-induced alleviation of hippocampal injury in rats following SD

To further determine the mechanism by which propofol reduced autophagy caused by SD, we used the autophagy enhancer rapamycin, and the autophagy inhibitor 3-methyladenine (3-MA), as interventional factors in a rat model of SD. Rats were injected intraperitoneally with rapamycin or 3-MA after SD, then with or without 30 mg/kg propofol 30 minutes later. Various tests and inspections were conducted 1 hour after the rats had been awakened, and as shown in , the expression levels of Beclin1 and LC3 in the group which were administered propofol or/and the 3-MA were significantly lower than those in the SD group and the R group. However, propofol did not reverse the effect of rapamycin in the PR group and did not enhance the effect of 3-MA in the P + 3-MA group.
Figure 3

Effects of autophagy inhibition and enhancement on hippocampal autophagy-related proteins after sleep deprivation. (A) Western blotting bands of Beclin1 and LC3 II/I in the hippocampus of rats. (B,C) The effects of autophagy inhibition and enhancement on hippocampal autophagy-related proteins after sleep deprivation. *P<0.05, significantly different from the control group; #P<0.05, significantly different from the SD group.

Effects of autophagy inhibition and enhancement on hippocampal autophagy-related proteins after sleep deprivation. (A) Western blotting bands of Beclin1 and LC3 II/I in the hippocampus of rats. (B,C) The effects of autophagy inhibition and enhancement on hippocampal autophagy-related proteins after sleep deprivation. *P<0.05, significantly different from the control group; #P<0.05, significantly different from the SD group. We also used transmission electron microscopy to observe (×25,000) mitochondria in the hippocampal neurons, as shown in . This showed that after SD, the hippocampal membrane structure was surrounded by phagocytic bubbles, some of which were typical peanut-shaped, the mitochondrial crest shape in the mitochondria was blurred, and in some cases, mitochondrial fragmentation was evident. SD rats injected with propofol and/or 3-MA showed significant improvement with regards to this phenomenon, while those injected with propofol and/or rapamycin did not show any significant improvement.
Figure 4

Mitochondrial morphology of hippocampal neurons, as determined by transmission electron microscopy. The box below is the enlarged image of autophagosomes in the upper figure.

Mitochondrial morphology of hippocampal neurons, as determined by transmission electron microscopy. The box below is the enlarged image of autophagosomes in the upper figure. Behavioral experiments carried out with the Morris water maze showed similar results to those listed above (). The results of the fifth day of the hidden platform test showed that compared with the C group, the escape latency of rats in the SD group, SD-F group, PR group, and R group was significantly longer, while there was no significant difference in those in group P, P + 3-MA, and 3-MA group compared with the C group. Rats in the P group, 3-MA group, and P + 3-MA group displayed shorter escape latency compared with the SD group on the fifth day of the hidden platform test (), while those in the SD group, SD-F group, PR group, and R group crossed the hidden platform fewer times and stayed in the target quadrant for a shorter time in contrast with the control group (). However, propofol or/and 3-MA administration alleviated the impaired memory of SD rats significantly. As shown in , rats in the P group and P + 3-MA group passed through the hidden platform more times and stayed in the target quadrant for a longer time, compared with the SD group. The representative swimming tracks of rats in each group are illustrated in to show the difference among the groups. Collectively, these data suggested SD aggravated cognitive impairment in rats, while propofol and 3-MA alleviated it.
Figure 5

Cognitive function of rats after sleep deprivation, as determined by the Morris water maze. (A) Escape latency of rats in the hidden platform test for five consecutive days. (B) Escape latency times in the 5th day. (C) Space exploration times on the 6th day. (D) Representative swimming tracks of space exploration experiment of rats. Compared with C group, *P<0.05, significantly different from the control group; #P<0.05, significantly different from the SD group.

Cognitive function of rats after sleep deprivation, as determined by the Morris water maze. (A) Escape latency of rats in the hidden platform test for five consecutive days. (B) Escape latency times in the 5th day. (C) Space exploration times on the 6th day. (D) Representative swimming tracks of space exploration experiment of rats. Compared with C group, *P<0.05, significantly different from the control group; #P<0.05, significantly different from the SD group. Accordingly, these results suggested several conclusions. First, that SD could lead to enhanced autophagy; second, that propofol and 3-MA could reduce autophagy and mitochondrial damage in hippocampal neurons caused by SD, which was an effect similar to that of 3-MA; and third, the effect of propofol could be reversed by rapamycin.

Role of the mitophagy pathway in the propofol-induced alleviation of hippocampal mitochondrial damage in rats after SD

The above transmission electron microscopy results () suggest SD caused morphological damage in the hippocampal mitochondria of rats after SD and that propofol reduced this damage. We next hypothesized that propofol alleviated hippocampal mitochondrial damage after SD in rats via the PINK1/Parkin mitophagy signaling pathway. As shown in , LC3, PINK1, and Parkin expression levels were detected using qRT-PCR, and the results demonstrate the expressions of mRNA of LC3, PINK1, and Parkin in the group receiving propofol were significantly lower than those in the SD group not receiving it. Furthermore, the expression of proteins of LC3, PINK1, and Parkin in the hippocampus measured by immunohistochemistry produced similar results (). Moreover, the administration of propofol could reduce the expression levels of PINK1, P62, LC3, and Beclin1 protein, measured by Western blotting, after SD ().
Figure 6

Detection of mitophagy-related protein and gene expression. (A-C) Relative expression levels of LC3, Parkin, and PINK1 genes by qRT-PCR. (D-I) Assessment of LC3, PINK1, and Parkin proteins by immunohistochemistry. (J-O) Assessment of autophagy-related and mitophagy-related proteins by Western blotting. *P<0.05, significantly different from the control group; #P<0.05, significantly different from the SD group.

Detection of mitophagy-related protein and gene expression. (A-C) Relative expression levels of LC3, Parkin, and PINK1 genes by qRT-PCR. (D-I) Assessment of LC3, PINK1, and Parkin proteins by immunohistochemistry. (J-O) Assessment of autophagy-related and mitophagy-related proteins by Western blotting. *P<0.05, significantly different from the control group; #P<0.05, significantly different from the SD group. In summary, our data indicated SD also caused an increase in excessive mitophagy and autophagy-related proteins, although this experiment did not show a dose-dependent effect on propofol.

Discussion

Autophagy is an important mechanism for maintaining cellular homeostasis. Dysregulated autophagy may be involved in many pathophysiological processes (8,26), and sleep fragmentation can also change the rhythm of hippocampal autophagy (27). Our data show that 96 hours of SD could simultaneously lead to the increased expression of autophagy-related proteins (Beclin1, LC3, and p62) in hippocampal cells, and impair learning, cognition, and memory in rats (). Homologous to the yeast Atg6, Beclin1is a key protein that mediates the localization of other autophagy proteins to pre-autophagosomes and combines with vacuolar protein sorting 34 (Vsp34) to form a complex that induces autophagy. Thus, Beclin1 is an important regulator of mammalian autophagosome formation (28). LC3 (microtubule-associated protein light chain 3, MAP LC3) was the first autophagosome marker protein to be identified in mammals and is homologous to the yeast autophagy-related gene Atg8. Similar to previous studies, SD has been shown to cause excessive levels of autophagy and may be one of the causes of impairment of learning and memory (8,29,30). Our study also observed obvious autophagic vesicles in rat hippocampal mitochondria after SD, then detected the relative expression of several mitophagy-related proteins (PINK1, Parkin, and p62), which are the initiating proteins of mitophagy (). This suggests SD induces excessive mitophagy at the same time as autophagy occurs, and both can be caused by mitochondrial dysfunction. However, previous studies have not reported the effect of SD on mitophagy. SD or sleep disorders can alter energy metabolism in the brain and affect glycogen transport and uptake (2,3,6), and it is well known that SD can cause an increase in ROS and damage to mitochondria, which in turn induces apoptosis (5,31,32). Compared with other organelles, mitochondria often change shape under physiological and pathological conditions. However, once mitochondria are damaged by stress levels which are beyond their ability to withstand, a greater response is activated in terms of degradation, that is, mitophagy. The mitochondrial quality control system can repair partially damaged mitochondria and clear those which cannot be repaired. PINK1, located in the outer membrane of the mitochondria, accumulates and recruits Parkin during mitochondrial injury, which can cause ubiquitination in the mitochondrial stroma and ultimately remove damaged mitochondria (33,34). Parkin on the mitochondrial membrane is activated by phosphorylation by PINK1, which in turn induces the ubiquitination and aggregation of E3, causing ubiquitinated mitochondria to be recognized by connexin p62. As a multifunctional adaptor protein, p62/SQSTM1 mediates the binding of ubiquitin to autophagosomes, and the combination of p62 and LC3 connects mitochondria to the autophagic vesicle membrane and causes mitophagy (34-36). Both in vivo and in vitro models of stroke, excessive activation of mitophagy will lead to increased neuronal death (37,38). In another animal experiment, excessive mitophagy aggravated the brain damage in rats following cardiac arrest and cardiopulmonary resuscitation (39). Therefore, excessive mitophagy may be related mitochondrial damage and dysfunction by excessive levels of stress caused by SD and may also be one of the causes of learning and memory impairment. As an antioxidant, propofol can be activated by inhibiting NADPH oxidase-mediated mast cell degranulation, protecting intestinal epithelial cells from ischemia-reperfusion injury. It can also inhibit the expression of the autophagy-related proteins LC3 and Beclin1 induced by lipopolysaccharides (40). Studies have shown that propofol can inhibit the overexpression of synaptophysin by inhibiting excessive autophagy, protecting the learning and memory abilities of depressed rats after Electroconvulsive shock (41). Similar to previous research, the results of the present study showed propofol intervention could reduce the expression levels of autophagy-related genes and proteins after SD in rats and improve the morphology of the mitochondria to a normal state. It has been suggested that propofol intervention could alleviate the autophagy of the rat hippocampus caused by SD. At the same time, after the administration of propofol, the learning and memory impairment caused by SD was improved. Mammalian target of rapamycin (mTOR) is involved in neural development, synaptic plasticity, learning, and memory, and can combine with other proteins to form two complexes with different functions: mTORC1 and mTORC2. Activated mTORC1 phosphorylates serine/threonine kinase UNC51-like kinase 1 and autophagy-related protein 13, preventing it from forming a complex with the pre-autophagosomal structure, thereby inhibiting autophagy. Based on this, it was considered to be the core protein controlling autophagy (42). Rapamycin is currently the most widely used autophagy enhancer (43). It inhibits the activity of mTORC1 by binding to the FKBP12 region on mTORC1, thereby activating autophagy. 3-MA is a class III phosphoinositide 3-kinase inhibitor and predominantly acts via the activity of Beclin1 and the Vps34 complex to inhibit autophagy (44). To further prove that its effect on improving learning and memory impairment was by inhibiting excessive autophagy, we use rapamycin and 3-MA to block or replace the effect of propofol, and the results suggested its effect could be reversed by rapamycin in rats after SD. This suggests the impairment of hippocampal function in rats after SD may be related to the excessive activation of autophagy. Rapamycin reversed the effect of propofol that inhibited the autophagy of hippocampal cells during anesthesia in elderly rats and 6-day-old rats (45,46). On the other hand, in our experiments, 3-MA reduced autophagy and improved behavioral experimental results. This suggested the improvement of function in the rat hippocampus after SD may be related to the inhibition of autophagy (44). The experimental results of Cui et al. also suggest that both propofol and 3-MA significantly inhibited the expression of autophagy-related proteins in hippocampal cells caused by ischemia-reperfusion (47). Propofol has also been shown to alleviate autophagy and apoptosis induced by ischemia-reperfusion by inhibiting the expression of autophagy-related proteins such as Beclin1, LC3, and mTOR (48). These findings indicated propofol prevented memory and learning deficits induced by SD, by inhibiting excessive autophagy. In our experiments, the mRNA and protein levels of PINK1 and Parkin in the hippocampus of rats increased after SD and decreased after propofol intervention. This suggests that propofol may play a role through the PINK1/Parkin mitophagy pathway. Propofol inhibits autophagy while inhibiting excessive mitophagy to maintain the balance of cellular mitochondrial metabolism. These effects may be another reason why propofol alleviates learning and memory impairment caused by SD. Propofol has been reported to participate in the regulation of autophagy and the protection of mitochondria. Its pretreatment can also inhibit the expression of endothelial microvesicles and microcystin-1 induced by hypoxia/reoxygenation in human umbilical vein endothelial cells. Moreover, propofol pretreatment also reduced mitochondrial damage caused by stress by inhibiting the mitochondrial apoptosis pathway (49), and in a previous study, Liang (50) found that propofol reduced the expression of PINK1 in the hippocampal cells of newborn rats. However, it is important to note that autophagy is a common life phenomenon for eukaryotes, and its existence is limited to more or less rather than existence or absence. Excessive restrictions on autophagy or enhanced autophagy may also cause new problems. In the present study, we confirmed that propofol inhibited the increased expression of autophagy-related and mitophagy-related proteins in the rat hippocampus after SD, thereby inhibiting autophagy and mitophagy in hippocampus cells. These results indicate that SD can lead to enhanced autophagy and mitophagy in the rat hippocampus and may provide an experimental basis for propofol to be incorporated into new clinical applications. The article’s supplementary files as
  50 in total

Review 1.  Mechanisms of mitophagy.

Authors:  Richard J Youle; Derek P Narendra
Journal:  Nat Rev Mol Cell Biol       Date:  2011-01       Impact factor: 94.444

2.  Modafinil protects hippocampal neurons by suppressing excessive autophagy and apoptosis in mice with sleep deprivation.

Authors:  Yin Cao; Qinglin Li; Lulu Liu; Hui Wu; Fei Huang; Changhong Wang; Yunyi Lan; Fang Zheng; Faping Xing; Qiang Zhou; Qi Li; Hailian Shi; Beibei Zhang; Zhengtao Wang; Xiaojun Wu
Journal:  Br J Pharmacol       Date:  2019-04-02       Impact factor: 8.739

3.  Transcranial near-infrared photobiomodulation attenuates memory impairment and hippocampal oxidative stress in sleep-deprived mice.

Authors:  Farzad Salehpour; Fereshteh Farajdokht; Marjan Erfani; Saeed Sadigh-Eteghad; Siamak Sandoghchian Shotorbani; Michael R Hamblin; Pouran Karimi; Seyed Hossein Rasta; Javad Mahmoudi
Journal:  Brain Res       Date:  2018-01-04       Impact factor: 3.252

4.  Paradoxical sleep deprivation and sleep recovery: effects on the hypothalamic-pituitary-adrenal axis activity, energy balance and body composition of rats.

Authors:  D C Hipólide; D Suchecki; A Pimentel de Carvalho Pinto; E Chiconelli Faria; S Tufik; J Luz
Journal:  J Neuroendocrinol       Date:  2006-04       Impact factor: 3.627

5.  Sleep neurobiology: relevance for mechanistic studies of anaesthesia.

Authors:  R Lydic; J F Biebuyck
Journal:  Br J Anaesth       Date:  1994-05       Impact factor: 9.166

6.  Propofol anesthesia and sleep: a high-density EEG study.

Authors:  Michael Murphy; Marie-Aurélie Bruno; Brady A Riedner; Pierre Boveroux; Quentin Noirhomme; Eric C Landsness; Jean-Francois Brichant; Christophe Phillips; Marcello Massimini; Steven Laureys; Giulio Tononi; Mélanie Boly
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

7.  The recovery from transient cognitive dysfunction induced by propofol was associated with enhanced autophagic flux in normal healthy adult mice.

Authors:  Sooyoung Cho; Yeon Joo Jung; Eun Cheng Suh; Hee Jung Baik; Jong In Han; Guie Yong Lee; Kyung Eun Lee
Journal:  Brain Res       Date:  2018-07-10       Impact factor: 3.252

8.  Trehalose enhances bone fracture healing in a rat sleep deprivation model.

Authors:  Xingquan Xu; Rongliang Wang; Ziying Sun; Rui Wu; Wenjin Yan; Qing Jiang; Dongquan Shi
Journal:  Ann Transl Med       Date:  2019-07

9.  Propofol prevents autophagic cell death following oxygen and glucose deprivation in PC12 cells and cerebral ischemia-reperfusion injury in rats.

Authors:  Derong Cui; Li Wang; Aihua Qi; Quanhong Zhou; Xiaoli Zhang; Wei Jiang
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.752

10.  Rapid Eye Movement Sleep Deprivation Induces Neuronal Apoptosis by Noradrenaline Acting on Alpha1 Adrenoceptor and by Triggering Mitochondrial Intrinsic Pathway.

Authors:  Bindu I Somarajan; Mudasir A Khanday; Birendra N Mallick
Journal:  Front Neurol       Date:  2016-03-07       Impact factor: 4.003

View more
  3 in total

1.  Valerian essential oil for treating insomnia via the serotonergic synapse pathway.

Authors:  Wenfei Wang; Yichun Wang; Qiuting Guo; Huiting Li; Zhaoqiang Wang; Jia Li; Taotao Li; Tiantian Tang; Yujiao Wang; Yanzhuo Jia; Yao Wang; Junbo Zou; Yajun Shi; Dongyan Guo; Ming Yang; Xiaofei Zhang; Jing Sun
Journal:  Front Nutr       Date:  2022-07-28

Review 2.  Mitochondrial autophagy in the sleeping brain.

Authors:  Sofia Mauri; Mariavittoria Favaro; Greta Bernardo; Gabriella M Mazzotta; Elena Ziviani
Journal:  Front Cell Dev Biol       Date:  2022-08-24

3.  Intervention Effects of Okra Extract on Brain-Gut Peptides and Intestinal Microorganisms in Sleep Deprivation Rats.

Authors:  Jingru Wu; Mingxue Cao; Ming Hu; Yu Gong; Jianming Xue; Yilin Yang; Hairui Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-24       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.